Sorry Nick. That was a confusing post. The whole sp thing for these biotechs has everyone jumpy, including me. I have faith in the science but have nothing more to offer than wild ideas. I can't help thinking though that at some point there'll be a coming together between IMU & CHM. ( I could be waaaaaaaaay off )
JC is the boss over there. Calm influence and we need calm. Not placed to say that will, would or could ever eventuate and for me it would be an 'as well' not an 'instead'. Hope that explains things.
Ann: Imugene Appoints Dr John Byon as SVP Clinical Development, page-47
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $413.7K | 8.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 112 | 14818485 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 13411 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |